Exercise-induced asthma (EIA) is a type of asthma that is triggered by physical activity. It affects up to 90 percent of people with asthma and can cause a range of symptoms including coughing, wheezing, chest tightness, and difficulty breathing. While EIA can make it difficult to exercise, there are a number of strategies that can help people with EIA manage their symptoms and breathe easier.
Exercise-induced asthma (EIA) is a type of asthma that is triggered by physical activity. It is caused by the narrowing of the airways due to the release of certain chemicals in response to exercise. This narrowing of the airways can lead to a range of symptoms including coughing, wheezing, chest tightness, and difficulty breathing. EIA can affect people of any age, but it is more common in children and young adults. It is estimated that up to 90 percent of people with asthma may experience EIA.
EIA is caused by the narrowing of the airways in response to certain triggers. These triggers can include cold weather, dry air, air pollution, and physical activity. When exercising, the air you breathe in is colder and drier than the air you breathe out. This can cause the airways to narrow, which leads to the symptoms of EIA. Other factors such as air pollution and allergens can also contribute to the narrowing of the airways.
The most important way to manage EIA is to avoid triggers. If possible, try to avoid exercising in cold or dry air, or when there is a lot of air pollution. Additionally, if you are allergic to certain substances, try to avoid contact with them. In addition to avoiding triggers, there are a number of strategies that can help you manage your EIA symptoms. These include: • Taking medication before exercising: Inhaled medications such as bronchodilators can help to open up the airways and reduce symptoms. • Warming up: A warm up before exercising can help to reduce the risk of EIA symptoms. • Cooling down: A cool down after exercising can help to reduce the risk of EIA symptoms. • Pacing yourself: Taking frequent breaks during exercise can help to reduce the risk of EIA symptoms. • Wearing a mask: Wearing a mask during exercise can help to reduce the risk of EIA symptoms. • Hydrating: Drinking plenty of fluids before, during, and after exercise can help to reduce the risk of EIA symptoms.
Exercise-induced asthma (EIA) is a type of asthma that is triggered by physical activity. It can cause a range of symptoms including coughing, wheezing, chest tightness, and difficulty breathing. While EIA can make it difficult to exercise, there are a number of strategies that can help people with EIA manage their symptoms and breathe easier. These include avoiding triggers, taking medication before exercising, warming up, cooling down, pacing yourself, wearing a mask, and hydrating. With the right treatment plan, people with EIA can lead an active and healthy life.
1.
Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.
2.
Effective for localizing small, non-palpable breast lesions is ultrasound-guided localization with magnetic seeds.
3.
Long-term study links chronic conditions in midlife to higher cancer risk and mortality
4.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
5.
When does a melanoma metastasize? Implications for management
1.
Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results
2.
The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies
3.
Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025
4.
Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked
5.
Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation